Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors

Camila M L Machado1, Magdalena Skubal2, Katja Haedicke2

  • 1Laboratorio de Investigação Médica de Medicina Nuclear-LIM-43, Departamento de Radiologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo 05403911, Brazil; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Insights

Prostate cancer cell membrane particles (Mp) expressing PSMA can transfer PSMA and alter the tumor microenvironment, promoting angiogenesis and lymphangiogenesis. This highlights PSMA-Mp

Area of Science:

  • Oncology
  • Biotechnology
  • Molecular Biology

Background:

  • Cell membrane-derived particles (Mp) are shed from tumor cells and considered for drug delivery due to tumor-targeting capabilities.
  • Prostate-specific membrane antigen (PSMA) is highly expressed in Mp from prostate cancer (PCa) with poor prognosis.
  • Previous studies showed PSMA in Mp from PCa cell lines and patients, but without established pathophysiological effects.

Purpose of the Study:

  • To investigate the pathophysiological effects of PSMA-expressing Mp (PSMA-Mp) compared to PSMA-non-expressing Mp (WT-Mp).
  • To determine if PSMA-Mp can transfer PSMA and alter the tumor microenvironment.
  • To analyze the impact of PSMA-Mp on angiogenesis and lymphangiogenesis.

Main Methods:

  • In vitro and in vivo comparison of PSMA-Mp and WT-Mp.
  • Analysis of PSMA transfer from Mp to recipient cells.
  • Assessment of VEGF-A secretion and 4E-binding protein 1 (4EBP-1) phosphorylation.

Main Results:

  • PSMA-Mp successfully transferred PSMA and induced new phenotypic characteristics in the tumor microenvironment.
  • Increased secretion of vascular endothelial growth factor-A (VEGF-A) and other pro-angiogenic/pro-lymphangiogenic mediators was observed.
  • Elevated 4E-binding protein 1 (4EBP-1) phosphorylation was detected following PSMA transfer.

Conclusions:

  • PSMA-expressing Mp possess the ability to transfer PSMA and modify the tumor microenvironment.
  • PSMA-Mp contribute to pro-angiogenic and pro-lymphangiogenic processes, potentially influencing PCa progression.
  • These findings suggest a role for PSMA-Mp in the pathophysiology of prostate cancer.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K